Caitong International Asset Management Co., LTD Arbutus Biopharma Corp Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 823 shares of ABUS stock, worth $2,534. This represents 0.0% of its overall portfolio holdings.
Number of Shares
823Holding current value
$2,534% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABUS
# of Institutions
190Shares Held
111MCall Options Held
866KPut Options Held
608K-
Morgan Stanley New York, NY23.8MShares$73.3 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$41 Million27.3% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$35.6 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY9.47MShares$29.2 Million1.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.95MShares$27.6 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $462M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...